LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
© LexDana · beta
LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged unpatentability · clear

PTAB

Resolving AIA Amendment Burdens Unlikely to Move the Needle at the PTAB

Burden of Persuasion to Demonstrate Unpatentability on Petitioner The United States Patent and Trademark Office (USPTO) has issued a Notice of Proposed Rulemaking (NPRM) to allocate the burdens of persuasion on motions to amend in AIA trial proceedings…

October 23, 2019·PTAB·3 min read
Patent Prosecution

District Court Finds Mallinckrodt Patents Claim Unpatentable Natural Phenomena

Written by Marc Chatenay-Lapointe, Ph.D. and Agnes Juang, Ph.D. The recent district court ruling in INO Therapeutics LLC et al v. Praxair Distribution, Inc. et al employed the two-step analytical framework of Mayo/Alice to evaluate subject matter…

September 18, 2017·Patent Prosecution·4 min read
PTAB

Fresh From the Bench: Precedential Patent Cases From the Federal Circuit

Written by Peter Heuser, Schwabe, Williamson & Wyatt, P.C. In Mylan v. Aurobindo the Circuit affirms the grant of a preliminary injunction based upon the infringement of one of the three patents in suit. However, the panel reverses the injunction as to the…

May 19, 2017·PTAB·7 min read
LexDana
AskSearchRankingsInsightsPricingProfileContactTermsPrivacy
The LexDana Docket
Monthly — what shipped, who moved, what we published.
© 2026 LexDana, Inc.·Powered by Patexia data